Literature DB >> 12052468

The expression of extracellular-superoxide dismutase is increased by lysophosphatidylcholine in human monocytic U937 cells.

Masayuki Yamamoto1, Hirokazu Hara, Tetsuo Adachi.   

Abstract

Extracellular-superoxide dismutase (EC-SOD) [EC 1.15.1.1] is a secretory glycoprotein with an affinity for heparin-like proteoglycans. This enzyme locates in blood vessel walls at high levels and may be important for the antioxidant capability of vascular walls. Oxidative process plays an important role in atherogenesis. Lysophosphatidylcholine (lysoPC) is generated during oxidation of low-density lipoprotein (LDL) and is located within atherosclerotic plaques. Recently, lysoPC has been reported to induce transcription of a variety of cellular genes. In this study, we observed that lysoPC significantly increased the expression of EC-SOD mRNA and protein in human monocytic U937 cells, but not those of CuZn-SOD or Mn-SOD. Induced EC-SOD by lysoPC had a high affinity for heparin, and may bind to the endothelial cell surface. Very recently, it has been reported that exogenous addition of EC-SOD or overexpression of EC-SOD prevented endothelial cell-mediated oxidative modification of LDL. Therefore, it is speculated that EC-SOD is induced by lysoPC-stimulated monocytes as a feedback mechanism in vascular homeostasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052468     DOI: 10.1016/s0021-9150(02)00007-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.

Authors:  Cavin K Ward-Caviness; Tao Xu; Thor Aspelund; Barbara Thorand; Corinna Montrone; Christa Meisinger; Irmtraud Dunger-Kaltenbach; Astrid Zierer; Zhonghao Yu; Inga R Helgadottir; Tamara B Harris; Lenore J Launer; Andrea Ganna; Lars Lind; Gudny Eiriksdottir; Melanie Waldenberger; Cornelia Prehn; Karsten Suhre; Thomas Illig; Jerzy Adamski; Andreas Ruepp; Wolfgang Koenig; Vilmundur Gudnason; Valur Emilsson; Rui Wang-Sattler; Annette Peters
Journal:  Heart       Date:  2017-03-02       Impact factor: 5.994

2.  Metabolomics reveal 1-palmitoyl lysophosphatidylcholine production by peroxisome proliferator-activated receptor α.

Authors:  Haruya Takahashi; Tsuyoshi Goto; Yota Yamazaki; Kosuke Kamakari; Mariko Hirata; Hideyuki Suzuki; Daisuke Shibata; Rieko Nakata; Hiroyasu Inoue; Nobuyuki Takahashi; Teruo Kawada
Journal:  J Lipid Res       Date:  2014-12-15       Impact factor: 5.922

3.  Glutathione, polyamine, and lysophosphatidylcholine synthesis pathways are associated with circulating pro-inflammatory cytokines.

Authors:  Ming Liu; Hongwei Zhang; Zikun Xie; Yiheng Huang; Guang Sun; Dake Qi; Andrew Furey; Edward W Randell; Proton Rahman; Guangju Zhai
Journal:  Metabolomics       Date:  2022-09-30       Impact factor: 4.747

4.  Acinar ATP8b1/LPC pathway promotes macrophage efferocytosis and clearance of inflammation during chronic pancreatitis development.

Authors:  Wang-Jun Yang; Rong-Chang Cao; Wang Xiao; Xiao-Lou Zhang; Hao Xu; Meng Wang; Zhi-Tao Zhou; Huo-Ji Chen; Jia Xu; Xue-Mei Chen; Jun-Ling Zeng; Shu-Ji Li; Min Luo; Yan-Jiang Han; Xiao-Bing Yang; Guo-Dong Feng; Yu-Heng Lu; Yuan-Yuan Ni; Chan-Gui Wu; Jun-Jie Bai; Zi-Qi Yuan; Jin Jin; Guo-Wei Zhang
Journal:  Cell Death Dis       Date:  2022-10-22       Impact factor: 9.685

Review 5.  An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System.

Authors:  Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

6.  Metabolomic profiling of patients with high gradient aortic stenosis undergoing transcatheter aortic valve replacement.

Authors:  Daniela Haase; Laura Bäz; Marcus Franz; P Christian Schulze; Tarek Bekfani; Sophie Neugebauer; Michael Kiehntopf; Sven Möbius-Winkler
Journal:  Clin Res Cardiol       Date:  2020-10-14       Impact factor: 5.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.